Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study. Mordoh J, Pampena MB, Aris M, Blanco PA, Lombardo M, von Euw EM, Mac Keon S, Yépez Crow M, Bravo AI, O'Connor JM, Orlando AG, Ramello F, Levy EM, Barrio MM. Front Immunol. 2017 May 31;8:625. doi: 10.3389/fimmu.2017.00625. eCollection 2017
Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells. Arriaga JM, Bravo AI, Mordoh J, Bianchini M. Oncol Rep. 2017 May;37(5):2633-2651. doi: 10.3892/or.2017.5547
In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells. Madorsky Rowdo FP, Barón A, von Euw EM, Mordoh J. Oncol Rep. 2017 Mar;37(3):1367-1378. doi: 10.3892/or.2017.5363
Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15. Rocca YS, Roberti MP, Juliá EP, Pampena MB, Bruno L, Rivero S, Huertas E, Sánchez Loria F, Pairola A, Caignard A, Mordoh J, Levy EM. Front Immunol. 2016 Oct 10;7:413. eCollection 2016.
Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine. Pizzurro GA, Tapia IJ, Sganga L, Podhajcer OL, Mordoh J, Barrio MM. Cancer Immunol Immunother. 2015 Nov;64(11):1393-406. doi: 10.1007/s00262-015-1743-z
Inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: a case report. Aris M, Bravo AI, Barrio MM, Mordoh J. Front Immunol. 2015 Mar 30;6:144. doi: 10.3389/fimmu.2015.00144. eCollection 2015.
Immunotherapy in Cancer: A Combat between Tumors and the Immune System; You Win Some, You Lose Some. Madorsky Rowdo FP, Baron A, Urrutia M, Mordoh J. Front Immunol. 2015 Mar 26;6:127. doi: 10.3389/fimmu.2015.00127.
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade. Roberti MP, Juliá EP, Rocca YS, Amat M, Bravo AI, Loza J, Coló F, Loza CM, Fabiano V, Maino M, Podhorzer A, Fainboim L, Barrio MM, Mordoh J, Levy EM. Eur J Immunol. 2015 May;45(5):1560-9. doi: 10.1002/eji.201445353.
Metallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapy. Arriaga JM, Greco A, Mordoh J, Bianchini M. Mol Cancer Ther. 2014 May;13(5):1369-81. doi: 10.1158/1535-7163. MCT-13-0944